Q-Line Biotec SME IPO

Q-Line Biotec SME

Q-Line Biotech Limited, incorporated in 2010 (originally as POCT Services Private Limited), is an Indian diagnostics and in-vitro diagnostics (IVD) enterprise. The company is actively engaged in developing, manufacturing, and marketing a diverse range of medical reagents, consumable testing kits, point-of-care (POC) devices, and automated pathology equipment. Serving diagnostic laboratories, hospitals, and medical colleges directly and through an expansive national distributor network since 2013, its operational capabilities span fields like Clinical Chemistry, Haematology, Immunodiagnostics, and Molecular Diagnostics.

Issue Price
343
Current GMP
₹129 (37.61%)
Overall Subscription
0x
Issue Size
₹214.48 Cr
Advertisement

Live Subscription by Application

CategoryApplications OfferedApplications ReceivedSubscription
QIB2,9701970.07x
FII
-36-
DFI
-29-
MF
-3-
Other
-129-
NII74349,78167.00x
bNII
49531,16262.95x
Corporate
-357-
Individual
-30,416-
Other
-389-
sNII
24818,61975.08x
Corporate
-133-
Individual
-18,154-
Other
-332-
IND2,5991,85,67771.44x
Total6,3122,35,65537.33x

Live Subscription by Shares

CategoryShares OfferedShares AppliedSubscription
QIB11.88 L14.72 Cr123.94x
FII
-2.07 Cr-
DFI
-3.23 Cr-
MF
-27.40 L-
Other
-9.15 Cr-
NII8.92 L13.05 Cr146.33x
bNII
5.94 L10.63 Cr178.82x
Corporate
-16.21 L-
Individual
-10.28 Cr-
Other
-18.93 L-
sNII
2.97 L2.42 Cr81.35x
Corporate
-1.61 L-
Individual
-2.36 Cr-
Other
-4.40 L-
IND20.79 L14.85 Cr71.44x
Total41.59 L42.62 Cr102.49x

Subscription Summary

QIB
Shares Applied:123.94x
Applications Offered:0.07x
NII
Shares Applied:146.33x
Applications Offered:67.00x
IND
Shares Applied:71.44x
Applications Offered:71.44x

Quick Stats

Total Categories3
IPO TypeSME
StatusAllotment Out

Get IPOwiz App

Track IPOs on the go with our mobile app

Download Now

Join us on Telegram for instant IPO updates!

Join Now

Data Last Updated

29 May 2026, 04:18 am

Auto-refreshing
Advertisement

Understanding Subscription Categories

QIB

Qualified Institutional Buyers

Includes FII, DFI, Mutual Funds, and other qualified institutions.

NII

Non-Institutional Investors

High net-worth individuals: bNII (₹10L+) and sNII (₹2L-₹10L).

IND

Individual Investors

Individual investors in SME IPOs up to ₹2 lakh.

Frequently Asked Questions

What is the current subscription status of Q-Line Biotec SME?
The current overall subscription for Q-Line Biotec SME is 0x. This indicates the total demand relative to the shares offered. Higher subscription typically suggests strong investor interest.
How to check Q-Line Biotec SME subscription status?
You can check Q-Line Biotec SME subscription status on IPOwiz, BSE website, NSE website, or your broker's platform. Subscription data is updated regularly during the IPO period from 21 May 2026 to 25 May 2026.
What do subscription numbers mean?
Subscription numbers show how many times the IPO is oversubscribed. For example, 0x means the IPO received 0x times more applications than shares available. Higher subscription in retail category generally means lower allotment chances.
When does Q-Line Biotec SME subscription close?
The subscription for Q-Line Biotec SME closes on 25 May 2026. Applications must be submitted before the closing time on this date. Late applications will not be accepted.
What is the difference between QIB, NII, and Individual (IND) subscription?
QIB (Qualified Institutional Buyers) includes mutual funds, FIIs, and other institutions. NII (Non-Institutional Investors) includes high net-worth individuals investing above ₹2 lakh. Individual (IND) includes individual investors with applications up to ₹2 lakh. Each category has separate subscription quotas.
How does subscription affect allotment chances?
Higher subscription in your category means lower allotment chances. For example, if retail subscription is 0x, it means there are 0x times more applications than shares available, making allotment competitive.
When will Q-Line Biotec SME allotment be finalized?
The allotment for Q-Line Biotec SME will be finalized and announced on 26 May 2026. You can check your allotment status on the registrar's website, BSE, NSE, or your demat account after this date.
What happens after subscription closes?
After subscription closes on 25 May 2026, the company and registrar process all applications. Allotment is finalized by 26 May 2026, and shares are credited to successful applicants' demat accounts before the listing date on 29 May 2026.
Can I apply after subscription closes?
No, you cannot apply after the subscription closes on 25 May 2026. All IPO applications must be submitted during the subscription period from 21 May 2026 to 25 May 2026. Late applications are automatically rejected.
What is the issue size and lot size for Q-Line Biotec SME?
The issue size for Q-Line Biotec SME is ₹214.48 Cr, and the lot size is 400 shares. The price range is ₹326.0 - ₹343.0. You must apply in multiples of the lot size.